FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
284 hedge funds and large institutions have $2.53B invested in Amicus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 114 increasing their positions, 88 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 289 → 284 (-5)
12% less capital invested
Capital invested by funds: $2.88B → $2.53B (-$350M)
36% less call options, than puts
Call options by funds: $3.21M | Put options by funds: $5.04M
Holders
284
Holding in Top 10
5
Calls
$3.21M
Puts
$5.04M
Top Buyers
| 1 | +$27.6M | |
| 2 | +$26.9M | |
| 3 | +$22.9M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$14.5M |
| 5 |
Two Sigma Investments
New York
|
+$10.1M |
Top Sellers
| 1 | -$28.6M | |
| 2 | -$25.7M | |
| 3 | -$24.8M | |
| 4 |
JP Morgan Chase
New York
|
-$21.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.79M |